1. Home
  2. PGEN vs STGW Comparison

PGEN vs STGW Comparison

Compare PGEN & STGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$3.96

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Stagwell Inc.

STGW

Stagwell Inc.

HOLD

Current Price

$7.24

Market Cap

1.6B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
STGW
Founded
1998
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
2013
2006

Fundamental Metrics

Financial Performance
Metric
PGEN
STGW
Price
$3.96
$7.24
Analyst Decision
Buy
Strong Buy
Analyst Count
5
7
Target Price
$8.33
$8.39
AVG Volume (30 Days)
5.6M
1.2M
Earning Date
05-13-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$230,981,000.00
$2,909,000,000.00
Revenue This Year
$1,115.92
$13.27
Revenue Next Year
$81.04
$4.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.39
52 Week Low
$1.23
$4.03
52 Week High
$5.47
$7.17

Technical Indicators

Market Signals
Indicator
PGEN
STGW
Relative Strength Index (RSI) 50.55 74.13
Support Level $3.49 $4.87
Resistance Level $4.44 N/A
Average True Range (ATR) 0.31 0.26
MACD 0.02 0.04
Stochastic Oscillator 57.83 99.16

Price Performance

Historical Comparison
PGEN
STGW

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About STGW Stagwell Inc.

Stagwell Inc is a challenger network using AI to deliver marketing and advertising solutions to its clients. It operates in five reportable segments: Marketing Services, Digital Transformation, Media and Commerce, Communications, and The Marketing Cloud. Maximum revenue is generated from the Marketing Services segment, which offers social media solutions, designs breakthrough brand campaigns, and creates immersive experiential marketing programs and social engagement strategies, helping clients connect with audiences across digital platforms. The various brands operating under this segment include 72 and Sunny, Anomaly, NRG, Harris Insights, TEAM, and Movers & Shaker. Geographically, the company generates maximum revenue from the United States, followed by the UK and other countries.

Share on Social Networks: